Related Experiment Video

Updated: Apr 25, 2026

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line
06:24

Oncogene Expression Analysis with Alterations in pH in a Pancreatic Ductal Cell Line

Published on: April 11, 2025

974

CXCR4 promotes GSK3β expression in pancreatic cancer cells via the Akt pathway

Shijie Ma1, Qianjun Li, Feng Pan

  • 1Department of Gastroenterology, Huai'an First People's Hospital, Nanjing Medical University, 6 Beijing Road West, Huai'an, 223300, Jiangsu, People's Republic of China.

International Journal of Clinical Oncology
|August 23, 2014
PubMed
Abstract

Insights

CXCR4 promotes pancreatic cancer invasion by upregulating glycogen synthase kinase-3β (GSK3β) expression through the Akt signaling pathway. This study elucidates a key mechanism in pancreatic cancer metastasis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • CXCR4 and GSK3β are implicated in pancreatic cancer proliferation and invasion.
  • The precise molecular role of CXCR4 in pancreatic cancer metastasis remains unclear.
  • CXCR4 inhibition has been shown to suppress GSK3β expression.

Purpose of the Study:

  • To investigate the molecular mechanism by which CXCR4 influences GSK3β expression.
  • To analyze the effect of CXCR4 on pancreatic cancer cell invasion.
  • To determine the role of the Akt pathway in CXCR4-mediated GSK3β regulation.

Main Methods:

  • Utilized PANC-1 and SW-1990 pancreatic cancer cell lines with stable CXCR4 modulation (upregulation/downregulation).
  • Employed Western blotting to assess protein expression levels of CXCR4, GSK3β, and MMP-2.
  • Conducted cell invasion assays to evaluate the impact of the Akt pathway on CXCR4-induced GSK3β expression.

Main Results:

  • Overexpression of CXCR4 led to increased GSK3β expression, while CXCR4 silencing reduced it.
  • CXCR4 activation correlated with increased cyclin D1 and p-Akt, and decreased p21 expression.
  • CXCR4 promoted PANC-1 cell invasion and GSK3β expression via the Akt signaling pathway, suggesting transcriptional regulation.

Conclusions:

  • CXCR4 significantly promotes GSK3β expression in pancreatic cancer cells.
  • The Akt cell signaling pathway is a key mediator of CXCR4's effect on GSK3β.
  • Understanding this CXCR4-Akt-GSK3β axis offers potential therapeutic targets for pancreatic cancer metastasis.

More Related Videos

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators07:41

A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators

Published on: February 20, 2018

8.4K
Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection11:00

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection

Published on: June 23, 2023

2.4K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
10.1K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
7.3K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.8K